Sarepta Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $2.22B | $2.98B | $1.50B |
| FY2021 | $2.22B | $3.15B | $2.12B |
| FY2022 | $2.74B | $3.13B | $966.8M |
| FY2023 | $2.41B | $3.26B | $428.4M |
| FY2024 | $2.44B | $3.96B | $1.10B |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $2.22B | $2.98B | $1.50B |
| FY2021 | $2.22B | $3.15B | $2.12B |
| FY2022 | $2.74B | $3.13B | $966.8M |
| FY2023 | $2.41B | $3.26B | $428.4M |
| FY2024 | $2.44B | $3.96B | $1.10B |